Since this board is speculating that 1 of the 2 FOB's in the first stage of a potential total of 6 FOB's in the BAX/MNTA collaboration is Orencia. It's interesting to note that worldwide sales are up 25% YoY and were $257M in 4Q11 worldwide with YE2011 sales of $917M. Giving a 2012 worldwide run rate of >$1 Billion.
Not as big as the other speculated FOB - Humira - but still respectable....
Market Data 
Markets 
AI
